关税影响

Search documents
美联储5月议息会议前瞻:按兵不动,静待政策明朗化
Jin Shi Shu Ju· 2025-05-07 06:38
SHMET 网讯:美联储最新利率决定将于北京时间周四凌晨2:00公布,鲍威尔的新闻发布会将于凌晨2:30开始。本次会议不会公布最新的经济预测摘要 (SEPs),更新的预测需等到6月会议。 在强于预期的4月就业报告发布后,市场普遍预计美联储将维持利率在4.25%-4.50%不变。货币市场目前认为,本次会议仅有2%的概率降息25个基点, 而全年累计降息预期为72个基点。 本次会议以及鲍威尔的新闻发布会上,焦点将继续集中美联储官员在对关税影响的评论,以及指引上。然而,美联储很可能重申其观望立场,以观察特 朗普的关税如何反映到"硬数据"中,并帮助美联储决定下一步行动。 继上周五美国就业报告强劲之后,高盛集团和巴克莱银行都将下一次降息预测从6月推迟到7月。值得注意的是,花旗虽维持年内125个基点的降息预 测,但首次降息时点从5月延至6月。 政策声明与鲍威尔表态 随后的新闻发布会上,鲍威尔提供的主要信息很可能重复"FOMC已做好充分准备,在获得更清晰的信息之前不改变政策"的说法。 高盛经济学家在其FOMC前瞻报告中提出了2个关键点 "软数据"VS"硬数据": 当前数据走势呈现出典型的事件驱动型放缓特征:调查类"软数据"迅 ...
受关税影响 加拿大三月对美出口环比下降6.6%
news flash· 2025-05-06 21:13
当地时间5月6日,加拿大统计局公布的数据显示,受到美国关税影响,今年3月份加拿大对美国的商品 出口环比下降了6.6%,商品总值较上月减少了37亿加元,降至520亿加元。与此同时,加拿大对美国以 外国家的出口猛增。3月份加拿大对美国以外国家的出口增长了24.8%,创下有记录以来的第二大增 幅,几乎抵消对美贸易的减少。此消彼长之下,加拿大3月商品出口略微下降了0.2%。(央视新闻) ...
UFP Technologies(UFPT) - 2025 Q1 - Earnings Call Transcript
2025-05-06 15:02
UFP Technologies (UFPT) Q1 2025 Earnings Call May 06, 2025 10:00 AM ET Company Participants Ronald Lataille - SVP, Treasurer & CFOR. Jeffrey Bailly - Chairman & CEOJaeson Schmidt - Director of ResearchJustin Ages - Director - Equity ResearchAndrew Cooper - VP - Equity Research Conference Call Participants Brett Fishbin - Vice President & Senior Equity Research Analyst Operator Good day, and welcome to the UFP Technologies First Quarter of twenty twenty five Earnings Call. All participants will be in a liste ...
Regal Beloit(RRX) - 2025 Q1 - Earnings Call Transcript
2025-05-06 15:02
Regal Rexnord (RRX) Q1 2025 Earnings Call May 06, 2025 10:00 AM ET Company Participants Robert Barry - VP - IRLouis Pinkham - CEORobert Rehard - Executive VP & CFOMichael Halloran - Associate Director of ResearchJeffrey Hammond - Managing DirectorNigel Coe - Managing Director Conference Call Participants Julian Mitchell - Equity Research AnalystKyle Menges - Vice President & Equity Research AnalystTim Thein - Managing Director & Research AnalystChristopher Glynn - Managing Director and Senior Analyst Operat ...
TopBuild(BLD) - 2025 Q1 - Earnings Call Transcript
2025-05-06 14:02
TopBuild (BLD) Q1 2025 Earnings Call May 06, 2025 09:00 AM ET Company Participants PI Aquino - Vice President - Investor RelationsRobert Buck - President & CEORobert Kuhns - CFOAatish Shah - Equity ResearchStephen Kim - Senior Managing DirectorMichael Rehaut - Executive DirectorAdam Baumgarten - Managing DirectorPhilip Ng - Managing DirectorTrey Grooms - Managing DirectorKeith Hughes - Managing DirectorJeffrey Stevenson - Vice PresidentCollin Verron - Director Conference Call Participants Susan Maklari - Se ...
Regal Beloit(RRX) - 2025 Q1 - Earnings Call Transcript
2025-05-06 14:00
Regal Rexnord (RRX) Q1 2025 Earnings Call May 06, 2025 10:00 AM ET Speaker0 Good day, and welcome to the Regal Rexnord First Quarter Earnings Call. All participants will be in listen only mode. After today's presentation, there will be an opportunity to ask questions. Please note this event is being recorded. I would now like to turn the conference over to Rob Barry, Vice President of Investor Relations. Please go ahead. Speaker1 Great. Thank you, operator. Good morning and welcome to Regal Rexnord's first ...
AdaptHealth(AHCO) - 2025 Q1 - Earnings Call Transcript
2025-05-06 13:32
Financial Data and Key Metrics Changes - First quarter revenue was $777.9 million, a decline of 1.8% from the prior year quarter, but exceeded the midpoint of guidance by $13.1 million [19][4] - Adjusted EBITDA for the first quarter was $127.9 million, down 19.3% year-over-year, with an adjusted EBITDA margin of 16.4% [5][22] - Free cash flow was negative $100,000, an improvement from negative $38.9 million in the prior year quarter [5][23] Business Line Data and Key Metrics Changes - **Sleep Health Segment**: Revenue decreased by 2.8% to $316.4 million, with new setups at approximately 113,000, slightly below expectations [20] - **Respiratory Health Segment**: Revenue increased by 3.3% to $165.5 million, driven by stronger oxygen new setups [21] - **Diabetes Health Segment**: Revenue declined by 8% to $138.8 million, but showed signs of recovery with improved new starts and the lowest attrition rate in two years [21][12] - **Wellness at Home Segment**: Revenue increased by 0.7% to $157.2 million, offsetting revenue lost from disposed assets [22] Market Data and Key Metrics Changes - The addressable markets within the four segments are growing in aggregate by mid-single digits, driven by an aging U.S. population and increasing prevalence of chronic conditions [8][6] - The company serves 4.2 million patients across over 660 locations in all 50 states, indicating a strong geographic footprint [8] Company Strategy and Development Direction - The company aims to deliver consistent, sustainable organic growth by focusing on its four core segments and enhancing patient service excellence [6][10] - There is a commitment to improving operational workflows and patient experience, particularly in the Diabetes Health segment [10][12] - The company is reducing debt and exiting non-core product lines to sharpen strategic focus [14][24] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the ability to manage potential tariff impacts, indicating that current exposure is contained and manageable [15][16] - The company remains optimistic about the growth potential in the Diabetes Health segment and overall business despite current challenges [12][30] Other Important Information - The company has reduced its debt balance by $25 million in the first quarter, totaling $195 million over the last five quarters [13][24] - Full-year revenue expectations have been reduced by $40 million due to the sale of certain incontinence assets [25] Q&A Session Summary Question: Can you provide additional color on the improvement in the diabetes business? - Management noted positive movement in the pump business and sequential growth in new starts for continuous glucose monitors (CGMs) [28][29] Question: What is the situation with new starts in the sleep segment? - Management acknowledged a slight decline in new starts but emphasized confidence in addressing the issue through detailed plans [32][33] Question: Can you clarify the guidance changes related to asset sales? - The guidance change is exclusively for the incontinence asset sale, with no comments on the infusion asset sale until it is closed [29] Question: Are there opportunities for acquisitions in troubled markets? - Management confirmed ongoing M&A discussions and the potential for modest tuck-in acquisitions [60][59] Question: What is the company's exposure to tariffs for fiscal 2026? - Management indicated that they are feeling better about tariff exposure based on recent clarifications regarding product classifications [46][47] Question: How is the company positioned in the sleep market? - Management stated that improvements are needed in certain states to regain market share, with plans in place to address these challenges [54][55]
Driven Brands (DRVN) - 2025 Q1 - Earnings Call Transcript
2025-05-06 13:32
Driven Brands (DRVN) Q1 2025 Earnings Call May 06, 2025 08:30 AM ET Company Participants Joel Arnao - Senior Vice President of FP&A, Treasury and Investor RelationsJonathan Fitzpatrick - President and CEODaniel Rivera - Executive VP & COOMichael Diamond - CFO & Executive VPChris O'cull - Managing DirectorMark Jordan - Vice President - Equity ResearchChristian Carlino - Equity Research Associate Conference Call Participants Simeon Gutman - AnalystJustin Kleber - Senior Research AnalystSeth Sigman - Managing ...
TopBuild(BLD) - 2025 Q1 - Earnings Call Transcript
2025-05-06 13:00
TopBuild (BLD) Q1 2025 Earnings Call May 06, 2025 09:00 AM ET Speaker0 Ladies and gentlemen, thank you for standing by. Greetings, and welcome to TopBuild's First Quarter twenty twenty five Earnings Conference Call. At this time, all participants are in a listen only mode. A question and answer session will follow today's formal presentation. Please note this conference is being recorded. At this time, I'll now turn the conference over to your host, Pia Ichino, Vice President, Investor Relations. Pia, you m ...